This is a preview of subscription content, access via your institution.
Reference
Kuo M-C, et al. Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Frontiers in Oncology 10: 27 Nov 2020. Available from: URL: http://doi.org/10.3389/fonc.2020.584834
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1840, 49 (2021). https://doi.org/10.1007/s40278-021-90192-1
Published:
Issue Date: